The emerging class of GLP-1 agonist medication and GIP combined medications, such as tirzepatide, semaglutide, and the recently introduced retatrutide, provide promising advances in the treatment . Despite https://bpc157330266.bluxeblog.com/76262648/retatrutide-a-comparative-look